Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$115.71
-1.10%
Mkt Cap $9.66B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
Implied Upside
+8.3%
Consensus $125.29 vs current $115.71
NASDAQ·Healthcare·Biotechnology
$115.71
-1.10%
Mkt Cap $9.66B
Buy
11
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
+8.3%
Consensus $125.29 vs current $115.71